Balance Sheet Components (Tables)

12 Months Ended

Dec. 31, 2018

Balance Sheet Components

Schedule of Land, property and equipment

	December 31,		December 31,
	2018		2017
Land	$	396,247	$	396,247
Lab equipment		410,522		811,087
Clinical equipment		64,870		64,870
Software		62,637		62,637
Total property and equipment at cost		934,276		1,334,841
Accumulated depreciation		(173,659)		(112,773)
Property and equipment, net	$	760,617	$	1,222,068

Schedule of change in the carrying amount of goodwill

	December 31,		December 31,
	2018		2017
Beginning balance	$	5,210,821	$	—
Goodwill acquired in conjunction with the Napo merger		—		22,037,821
Impairment		(5,210,821)		(16,827,000)
Ending balance	$	—	$	5,210,821

Schedule of intangible assets

	December 31,		December 31,
	2018		2017
Developed technology	$	25,000,000	$	25,000,000
Accumulated developed technology amortization		(2,361,111)		(694,445)
Developed technology, net		22,638,889		24,305,555
In process research and development		8,800,000		11,100,000
Impairment		—		(2,300,000)
In process research and development, net		8,800,000		8,800,000
Trademarks		300,000		300,000
Accumulated trademark amortization		(28,333)		(8,333)
Trademarks, net		271,667		291,667
Total intangible assets, net	$	31,710,556	$	33,397,222

Schedule of estimated future amortization expense of intangible assets with finite lives

	Amounts
2019	$ 1,686,667
2020	$ 1,686,667
2021	$ 1,686,667
2022	$ 1,686,667
2023	$ 1,686,667
Thereafter	14,477,222
	$ 22,910,557

Schedule of accrued expenses

	December 31,		December 31,
	2018		2017
Accrued vacation	$	287,326	$	264,304
Accrued payroll		300,040		150
Accrued payroll tax		57,306		30,617
Accrued interest		917,482		659,961
Accrued consulting		660,370		1,785
Accrued research and development costs		106,607		668,850
Accrued legal costs		439,682		—
Accrued audit and tax services		96,150		40,000
Deferred rent		—		4,584
Accrued other		2,074,478		533,882
Total	$	4,939,441	$	2,204,133